{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:58:10Z","timestamp":1744221490623,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00404-020-05609-z","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T08:02:22Z","timestamp":1590566542000},"page":"741-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolic changes in follicular fluids of patients treated with recombinant versus urinary human chorionic gonadotropin for triggering ovulation in assisted reproductive technologies: a metabolomics pilot study"],"prefix":"10.1007","volume":"302","author":[{"given":"Maria Antonietta","family":"Castiglione Morelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assunta","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Crescenzo Antonio","family":"Schettini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatina","family":"Petruzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia","family":"Viggiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5970-5097","authenticated-orcid":false,"given":"Angela","family":"Ostuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"issue":"2","key":"5609_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1055\/s-0035-1546424","volume":"33","author":"ES Jungheim","year":"2015","unstructured":"Jungheim ES, Meyer M, Broughton DE (2015) Best practices for controlled ovarian stimulation. Semin Reprod Med 33(2):77\u201382","journal-title":"Semin Reprod Med"},{"issue":"5","key":"5609_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/er.2017-00236","volume":"39","author":"A Abbara","year":"2017","unstructured":"Abbara A, Clarke SA, Dhillo WS (2017) Novel concepts for inducing final oocyte maturation in In vitro fertilization treatment. Endocr Rev 39(5):593\u2013628","journal-title":"Endocr Rev"},{"issue":"1","key":"5609_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12958-018-0342-1","volume":"16","author":"T Haahr","year":"2018","unstructured":"Haahr T, Esteves SC, Humadain P (2018) Individualized controlled ovarian stimulation in expected poor-responders: an update. Reprod Biol Endocrinol 16(1):20. https:\/\/doi.org\/10.1186\/s12958-018-0342-1","journal-title":"Reprod Biol Endocrinol"},{"key":"5609_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1477-7827-8-102","volume":"8","author":"LA Cole","year":"2010","unstructured":"Cole LA (2010) Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 8:102. https:\/\/doi.org\/10.1186\/1477-7827-8-102","journal-title":"Reprod Biol Endocrinol"},{"key":"5609_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102037","author":"C Nwabuobi","year":"2017","unstructured":"Nwabuobi C, Arlier S, Schatz F, Guzeloglu-Kayisli O, Lockwood CJ, Kayisli UA (2017) hCG: Biological functions and clinical applications. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18102037","journal-title":"Int J Mol Sci"},{"key":"5609_CR6","first-page":"S60","volume":"1","author":"T Fournier","year":"2015","unstructured":"Fournier T, Guibourdenche J, Evain-Brion D (2015) Review: hCGs: different sources of production, different glycoforms and functions. Placenta 36. Suppl 1:S60\u2013S65","journal-title":"Suppl"},{"key":"5609_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ando.2016.04.012","volume":"77","author":"T Fournier","year":"2016","unstructured":"Fournier T (2016) Human chorionic gonadotropin: different glycoforms and biological activity depending on its source of production. Ann d\u2019Endocrinologie 77:75\u201381","journal-title":"Ann d\u2019Endocrinologie"},{"issue":"4","key":"5609_CR8","doi-asserted-by":"publisher","first-page":"e0176019","DOI":"10.1371\/journal.pone.0176019","volume":"12","author":"V Gunnala","year":"2017","unstructured":"Gunnala V, Melnick A, Irani M, Reichman D, Schattman G, Davis O, Rosenwaks Z (2017) Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: analysis of 10,427 IVF-ICSI cycles. PLoS ONE 12(4):e0176019. https:\/\/doi.org\/10.1371\/journal.pone.0176019","journal-title":"PLoS ONE"},{"issue":"4","key":"5609_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.6061\/clinics\/2014(04)10","volume":"69","author":"RB Le\u0101o","year":"2014","unstructured":"Le\u0101o RB, Esteves SC (2014) Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. Clinics 69(4):279\u2013293","journal-title":"Clinics"},{"issue":"3","key":"5609_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/glycob\/cwg020","volume":"13","author":"A Gervais","year":"2003","unstructured":"Gervais A, Hammel YA, Pelloux S, Lepage P, Baer G, Carte N, Sorokine O, Strub JM, Koerner R, Leize E, Van Dorsselaer A (2003) Glycosylation of human recombinant gonadotropins: characterization and batch-to-batch consistency. Glycobiology 13(3):179\u2013189. https:\/\/doi.org\/10.1093\/glycob\/cwg020","journal-title":"Glycobiology"},{"issue":"6","key":"5609_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/humupd\/dml029","volume":"12","author":"UH Stenman","year":"2006","unstructured":"Stenman UH, Tiitinen A, Alfthan H, Valmu L (2006) The classification, functions and clinical use of different isoforms of HCG. Human Reprod Update 12(6):769\u2013784. https:\/\/doi.org\/10.1093\/humupd\/dml029","journal-title":"Human Reprod Update"},{"issue":"7","key":"5609_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/humrep\/15.7.1446","volume":"15","author":"The European Recombinant Human Chorionic Gonadotropin Study Group","year":"2000","unstructured":"The European Recombinant Human Chorionic Gonadotropin Study Group (2000) Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG. Hum Reprod 15(7):1446\u20131451","journal-title":"Hum Reprod"},{"issue":"8","key":"5609_CR13","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/humrep\/dei035","volume":"20","author":"H Al-Inany","year":"2005","unstructured":"Al-Inany H, Aboulghar MA, Mansour RT, Proctor M (2005) Recombinant versus urinary gonadotropins for triggering ovulation in assisted conception. Hum Reprod 20(8):2061\u20132073","journal-title":"Hum Reprod"},{"issue":"3","key":"5609_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1472-6483(10)61433-2","volume":"13","author":"ML Uhler","year":"2006","unstructured":"Uhler ML, Beltsos AN, Grotjan HE, Lederer KJ, Lifchez AS (2006) Age-matched comparison of recombinant and urinary HCG for final follicular maturation. Reprod BioMed Online 13(3):315\u2013332","journal-title":"Reprod BioMed Online"},{"issue":"6","key":"5609_CR15","first-page":"543","volume":"10","author":"M Eftekhar","year":"2012","unstructured":"Eftekhar M, Khalili MA, Rahmani E (2012) The efficacy of recombinant versus urinary HCG in ART outcome. Iran J Reprod Med 10(6):543\u2013548","journal-title":"Iran J Reprod Med"},{"issue":"2","key":"5609_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/09513590.2012.730577","volume":"29","author":"M Bellavia","year":"2013","unstructured":"Bellavia M, de Geyter C, Streuli I, Ibecheole V, Birkh\u00e4user MH, Cometti BPS, de Ziegler D (2013) Randomized controlled trial comparing highly purified (HP-hCG) and recombinant hCG (r-hCG) for triggering ovulation in ART. Gynecol Endocrinol 29(2):93\u201397","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"5609_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10815-012-9919-3","volume":"30","author":"T Madani","year":"2013","unstructured":"Madani T, Mohammadi Yeganeh L, Ezabadi Z, Hasani F, Chehrazi M (2013) Comparing the efficacy of urinary and recombinant hCG on oocyte\/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial. J Assist Reprod Genet 30(2):239\u2013245","journal-title":"J Assist Reprod Genet"},{"key":"5609_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003719.pub3","author":"MA Youssef","year":"2011","unstructured":"Youssef MA, Al-Inany HG, Aboulghar M, Mansour R, Abou-Setta AM (2011) Recombinant versus urinary human chorionic gonadotropin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003719.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5609_CR19","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/14651858.CD003719.pub4","volume":"4","author":"MA Youssef","year":"2016","unstructured":"Youssef MA, Abou-Setta AM, Lam WS (2016) Recombinant versus urinary human chorionic gonadotropin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane database Syst Rev 4:3719. https:\/\/doi.org\/10.1002\/14651858.CD003719.pub4","journal-title":"Cochrane database Syst Rev"},{"issue":"1","key":"5609_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/rmb2.12066","volume":"17","author":"W Bagchus","year":"2017","unstructured":"Bagchus W, Wolna P, Uhl W (2017) Single-dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women. Reprod Med Biol 17(1):52\u201358","journal-title":"Reprod Med Biol"},{"issue":"5","key":"5609_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10815-018-1143-3","volume":"35","author":"MG Da Broi","year":"2018","unstructured":"Da Broi MG, Giorgi VSI, Wang F, Keefe DL, Albertini D, Navarro PA (2018) Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. J Assist Reprod Genet 35(5):735\u2013751. https:\/\/doi.org\/10.1007\/s10815-018-1143-3","journal-title":"J Assist Reprod Genet"},{"key":"5609_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1757-2215-6-11","volume":"6","author":"A La Marca","year":"2013","unstructured":"La Marca A, Grisendi V, Giulini S, Argento C, Tirelli A, Dondi G et al (2013) Individualization of the FSH starting dose in IVF\/ICSI cycles using the antral follicle count. J Ovarian Res 6:11. https:\/\/doi.org\/10.1186\/1757-2215-6-11","journal-title":"J Ovarian Res"},{"key":"5609_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/nbm.1488","volume":"23","author":"E Pi\u00f1ero-Sagredo","year":"2010","unstructured":"Pi\u00f1ero-Sagredo E, Nunes S, de los Santos MJ, Celda B, Esteve V (2010) NMR metabolic profile of human follicular fluid. NMR Biomed 23:485\u2013495","journal-title":"NMR Biomed"},{"issue":"2","key":"5609_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/humupd\/dmq039","volume":"17","author":"NE Baskind","year":"2011","unstructured":"Baskind NE, McRae C, Sharma V, Fisher J (2011) Understanding subfertility at a molecular level in the female through the application of nuclear magnetic resonance (NMR) spectroscopy. Hum Reprod Update 17(2):228\u2013241","journal-title":"Hum Reprod Update"},{"issue":"5","key":"5609_CR25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.fertnstert.2012.01.122","volume":"97","author":"M Wallace","year":"2012","unstructured":"Wallace M, Cottell E, Gibney MJ, McAuliffe FM, Wingfield M, Brennan L (2012) An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental potential, and implantation outcome. Fertil Steril 97(5):1078\u20131084","journal-title":"Fertil Steril"},{"issue":"4","key":"5609_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/REP-13-0184","volume":"146","author":"A O\u2019Gorman","year":"2013","unstructured":"O\u2019Gorman A, Wallace M, Cottell E, Gibney MJ, McAuliffe FM, Wingfield M et al (2013) Metabolic profiling of human follicular fluid identifies potential biomarkers of oocyte developmental competence. Reproduction 146(4):389\u2013395","journal-title":"Reproduction"},{"key":"5609_CR27","first-page":"1","volume":"28","author":"A Karaer","year":"2018","unstructured":"Karaer A, Tuncay G, Mumcu A, Dogan B (2018) Metabolomics analysis of follicular fluid in women with ovarian endometriosis undergoing in vitro fertilization. Syst Biol Reprod Med 28:1\u20139","journal-title":"Syst Biol Reprod Med"},{"issue":"11","key":"5609_CR28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10815-018-1281-7","volume":"35","author":"MA Castiglione Morelli","year":"2018","unstructured":"Castiglione Morelli MA, Iuliano A, Schettini SCA, Petruzzi D, Ferri A, Colucci P, Viggiani L, Cuviello F, Ostuni A (2018) NMR metabolomics study of follicular fluid in women with cancer resorting to fertility preservation. J Assist Reprod Genet 35(11):2063\u20132070","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"5609_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11306-019-1481-x","volume":"15","author":"MA Castiglione Morelli","year":"2019","unstructured":"Castiglione Morelli MA, Iuliano A, Schettini SCA, Petruzzi D, Ferri A, Colucci P, Viggiani L, Cuviello F, Ostuni A (2019) NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study. Metabolomics 15(2):19","journal-title":"Metabolomics"},{"key":"5609_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1477-7827-7-40","volume":"7","author":"A Revelli","year":"2009","unstructured":"Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P (2009) Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 7:40. https:\/\/doi.org\/10.1186\/1477-7827-7-40","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"5609_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/humupd\/dmx023","volume":"23","author":"T Bracewell-Milnes","year":"2017","unstructured":"Bracewell-Milnes T, Saso S, Abdalla H, Nikolau D, Norman-Taylor J, Johnson M et al (2017) Metabolomics as a tool to identify biomarkers to predict and improve outcomes in reproductive medicine: a systematic review. Hum Reprod Update 23(6):723\u2013736","journal-title":"Hum Reprod Update"},{"key":"5609_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1039\/C7MB90021J","volume":"13","author":"M Santonastaso","year":"2017","unstructured":"Santonastaso M, Pucciarelli A, Costantini S, Caprio F, Sorice A, Capone F et al (2017) Metabolomic profiling and biochemical evaluation of the follicular fluid of endometriosis patients. Mol Biosyst 13:1213\u20131222","journal-title":"Mol Biosyst"},{"issue":"2","key":"5609_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.fertnstert.2014.11.015","volume":"103","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB (2015) Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril 103(2):303\u2013316","journal-title":"Fertil Steril"},{"issue":"4","key":"5609_CR34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/humrep\/des458","volume":"28","author":"KE Hemmings","year":"2013","unstructured":"Hemmings KE, Maruthini D, Vyjayanthi S, Hogg JE, Balen AH, Campbell BK, Leese HJ, Picton HM (2013) Amino acid turnover by human oocytes is influenced by gamete developmental competence, patient characteristics and gonadotropin treatment. Hum Reprod 28(4):1031\u20131044","journal-title":"Hum Reprod"},{"key":"5609_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1071\/RD13007","volume":"26","author":"S Matoba","year":"2014","unstructured":"Matoba S, Bender K, Fahey AG, Mamo S, Brennan L, Lonergan P, Fair T (2014) Predictive value of bovine follicular components as markers of oocyte developmental potential. Reprod Fertil Dev 26:337\u2013345","journal-title":"Reprod Fertil Dev"},{"key":"5609_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1530\/REP-09-0345","volume":"139","author":"ML Sutton-McDowall","year":"2010","unstructured":"Sutton-McDowall ML, Gilchrist RB, Thompson JG (2010) The pivotal role of glucose metabolism in determining oocyte developmental competence. Reproduction 139:685\u2013695","journal-title":"Reproduction"},{"key":"5609_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fendo.2017.00114","volume":"8","author":"D Santi","year":"2017","unstructured":"Santi D, Casarini L, Alviggi C, Simoni M (2017) Efficacy of follicle-stimulating hormone (FSH) alone, FSH + luteinizing hormone, human menopausal gonadotropin or FSH + human chorionic gonadotropin on assisted reproductive technology outcomes in the \"Personalized\" medicine era: a meta-analysis. Front Endocrinol 8:114. https:\/\/doi.org\/10.3389\/fendo.2017.00114","journal-title":"Front Endocrinol"},{"issue":"6","key":"5609_CR38","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.fertnstert.2018.04.037","volume":"109","author":"BW Mol","year":"2018","unstructured":"Mol BW, Bossuyt PM, Sunkara SK, Garcia Velasco JA, Venetis C, Sakkas D, Lundin K, Simon C, Taylor HS, Wan R, Longobardi S, Cottell E, D'Hooghe T (2018) Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients. Fertil Steril 109(6):968\u2013979","journal-title":"Fertil Steril"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05609-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:39:33Z","timestamp":1622072373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05609-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5609"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05609-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the local ethical committee, Comitato Etico Unico Regionale per la Basilicata (CEUR, approval number: 2015\/00585), and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by CEUR on November 27, 2015.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for publication was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}